These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 6367434)
1. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434 [TBL] [Abstract][Full Text] [Related]
2. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. McCallum RW; Ippoliti AF; Cooney C; Sturdevant RA N Engl J Med; 1977 Feb; 296(7):354-7. PubMed ID: 319356 [TBL] [Abstract][Full Text] [Related]
3. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. McCallum RW; Fink SM; Lerner E; Berkowitz DM Gastroenterology; 1983 Jun; 84(6):1573-7. PubMed ID: 6132852 [TBL] [Abstract][Full Text] [Related]
4. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670 [TBL] [Abstract][Full Text] [Related]
5. Prevention of meal-induced heartburn and regurgitation with metoclopramide in patients with gastroesophageal reflux. Fuchs B; Bartolomeo RS Clin Ther; 1982; 5(2):179-85. PubMed ID: 6760968 [TBL] [Abstract][Full Text] [Related]
6. Effect of single and repeated doses of metoclopramide on the mechanisms of gastroesophageal reflux. Durazo FA; Valenzuela JE Am J Gastroenterol; 1993 Oct; 88(10):1657-62. PubMed ID: 8213706 [TBL] [Abstract][Full Text] [Related]
7. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Behar J; Brand DL; Brown FC; Castell DO; Cohen S; Crossley RJ; Pope CE; Winans CS Gastroenterology; 1978 Feb; 74(2 Pt 2):441-8. PubMed ID: 340333 [TBL] [Abstract][Full Text] [Related]
8. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446 [TBL] [Abstract][Full Text] [Related]
9. Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state. Behar J; Biancani P Gastroenterology; 1976 Mar; 70(3):331-5. PubMed ID: 765184 [TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452 [TBL] [Abstract][Full Text] [Related]
11. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux. Maddern GJ; Kiroff GK; Leppard PI; Jamieson GG J Clin Gastroenterol; 1986 Apr; 8(2):135-40. PubMed ID: 3745846 [TBL] [Abstract][Full Text] [Related]
12. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease. Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010 [TBL] [Abstract][Full Text] [Related]
13. Gastric emptying in infants: response to metoclopramide depends on the underlying condition. Hyman PE; Abrams CE; Dubois A J Pediatr Gastroenterol Nutr; 1988; 7(2):181-4. PubMed ID: 3351700 [TBL] [Abstract][Full Text] [Related]
14. Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide. Orr WC; Finn A; Wilson T; Russell J Am J Gastroenterol; 1990 Jun; 85(6):697-700. PubMed ID: 2191595 [TBL] [Abstract][Full Text] [Related]
15. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study. Petrokubi RJ; Jeffries GH Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients. McCallum RW; Kline MM; Curry N; Sturdevant RA Gastroenterology; 1975 May; 68(5 Pt 1):1114-8. PubMed ID: 1092585 [TBL] [Abstract][Full Text] [Related]
17. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis. Saco LS; Orlando RC; Levinson SL; Bozymski EM; Jones JD; Frakes JT Gastroenterology; 1982 Jun; 82(6):1369-73. PubMed ID: 7040158 [TBL] [Abstract][Full Text] [Related]
18. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study. Richter JE; Long JF Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282 [TBL] [Abstract][Full Text] [Related]
19. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease. Sherbaniuk R; Wensel R; Bailey R; Trautman A; Grace M; Kirdeikis P; Jewell L; Pare P; Levesque D; Farley A J Clin Gastroenterol; 1984 Feb; 6(1):9-15. PubMed ID: 6321588 [TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Larson JD; Patatanian E; Miner PB; Rayburn WF; Robinson MG Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]